Halle Moore
Director, Breast Medical Oncology · Cleveland Clinic Outpatient Center A - Austintown
Credentials: · · ·
History
Research
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
New England Journal of Medicine · 2022 · 2,268 citations
Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy
New England Journal of Medicine · 2015 · First of 25 authors · 397 citations
Systematic review or meta-analysis · Journal of Clinical Oncology · 2018 · 281 citations
18 papers
17 papers
15 papers
Gabriel Hortobagyi
14 papers
- JG
14 papers
11 papers
11 papers
11 papers
Clinical trials
- 2008–2010
Principal investigator · Terminated
Case Comprehensive Cancer Center
- 2003–2016
S0230 Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Principal investigator · Completed · Phase 3
SWOG Cancer Research Network
- 2014–2019
S1222 Trial (Everolimus, Anastrozole and Fulvestrant) in Post-Menopausal Stage IV Breast Cancer
Study chair · Terminated · Phase 3
SWOG Cancer Research Network
- 2003–2027
S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer
Study director · Active not recruiting · Phase 3
SWOG Cancer Research Network